A Phase I Study of Humanized 3F8 plus Interleukin-2 in Patients with High-Risk Neuroblastoma and GD2-Positive Tumors
Read Full Article
Phase I Study of Humanized 3F8 Monoclonal Antibody (Hu3F8) when Combined with Interleukin-2 in Patients With High-Risk Neuroblastoma and GD2-positive Solid Tumors
3F8 is an antibody that attaches to neuroblastoma cells and helps focus a patient’s own immune system - especially white blood cells - to attack neuroblastoma cells. Conventional 3F8 is made from mouse cells.